🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.

Investigational Treatment Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these profiles directly for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a flourishing market exists on messaging services, where communities with numerous of participants share comparison photos, injection guides and assertions of rapid British shipping. Vendors promote the substance there before redirecting customers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Express Concerns

However, physicians and pharmacists have warned that the distribution of what is still an unlicensed medication in the UK is worrisome and could lead to users injecting products of uncertain source.

Several professionals stated the demand for retatrutide could be connected to the rising price of licensed weight loss products such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the British medical regulations.

Some content creators try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate medicines, advertising, and customer regulations, risking penalties, prosecution or imprisonment.

Platform Reaction and Material Removal

According to the social media company, the platform has removed problematic material and banned related keywords and search suggestions. The organization stated it was dedicated to keeping the service safe and investing in strengthening compliance measures.

Digital Trading Activities

Investigations also discovered communities with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately displays channels with thousands of members, populated with photos of weight loss, glowing reviews and detailed instructions for preparing or injecting at home.

Within moments of entering one community, a seller shared WhatsApp details, where the majority of purchases take place. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about body mass, medical conditions or past usage.

Product Details and Costs

Within these groups, posts show dark colored packages with Royal Mail labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use injectors usually priced at £160 for 20 milligrams. When questioned how much time a injector should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for Telegram said it regularly moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting substances they cannot confirm. Even if the research behind this drug is valid, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.

Her staff has already encountered individuals injured by personal administration from unverified sources. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company experimental product not yet approved … may expose users to possibly serious health risks”.